Weaver

Kelly Weaver

Teaching Assistant Professor

Contact

Send an Email
Room
2096, HSC North, Floor 2
Address
PO Box 9177
Morgantown, WV 26506-9177
Additions & Corrections?

Positions

Research Associate

Organization:
School of Medicine
Classification:
Staff

Publications

 

  1. Huckaby AB, Gutierrez MDLP, Sze CW, Briggs B, Weaver KL, Yang E, Rocuskie Marker CM, Dublin SR, Hall JM, Ulicny SR, Pyles GM, Witt WT, Hudson MS, Land CA, Damron FH, Pritchett CL, Li C, Driscoll T, Sen-Kilic E, Barbier M. 2026. Development of a fluorescent reporter strain to facilitate studies of Borrelia burgdorferi pathogenesis. Microbiol Spectr 14:e02290-25.https://doi.org/10.1128/spectrum.02290-25
  2. Rocuskie-Marker CM, Huckaby AB, Conaway OM, Pyles GM, Dublin SR, Witt WT, Blackwood CB, de la Paz Gutierrez M, Hall JM, Ulicny SR, Padden E, Shephard S, Chapman J, Zapotocky T, Cannon-Blachere J, Peasak K, Rader NA, Miller M, Hankinson BR, Wong I, Long DA, Nunley M, Willis D, Lee KS, Cunningham C, Weaver KL, Damron FH, Barbier M. Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi. Vaccine. 2026 Jun 20;86:128696. doi: 10.1016/j.vaccine.2026.128696. Epub 2026 May 23. PMID: 42176436.
  3. Gutierrez MP, Huckaby AB, Yang E, Weaver KL, Hall JM, Hudson M, Dublin SR, Sen-Kilic E, Rocuskie-Marker CM, Miller SJ, Pritchett CL, Mummadisetti MP, Zhang Y, Driscoll T, Barbier M. Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice. Vaccine. 2024 Oct 24;42(24):126084. doi: 10.1016/j.vaccine.2024.06.051. Epub 2024 Jun 26. PMID: 38937181; PMCID: PMC12399139.
  4. Blackwood, C.B.; Croston, T.L.; Barnes, M.A.; Lemons, A.R.; Rush, R.E.; Goldsmith, T.; McKinney, W.G.; Anderson, S.; Weaver, K.L.; Sulyok, M.; et al. Optimization of Aspergillus versicolor Culture and Aerosolization in a Murine Model of Inhalational Fungal Exposure. J. Fungi 2023, 9, 1090. https://doi.org/10.3390/jof9111090
  5. Weaver KL, Bitzer GJ, Wolf MA, Pyles GM, DeJong MA, Dublin SR, Huckaby AB, Gutierrez MP, Hall JM, Wong TY, Warden M, Petty JE, Witt WT, Cunningham C, Sen-Kilic E, Damron FH, Barbier M. Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge. PLoS One. 2023 Nov 2;18(11):e0286925. doi: 10.1371/journal.pone.0286925. PMID: 37917623; PMCID: PMC10621807.
  6. Diallo BK, Ní Chasaide C, Wong TY, Schmitt P, Lee KS, Weaver K, Miller O, Cooper M, Jazayeri SD, Damron FH, Mills KHG. Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection. NPJ Vaccines. 2023 May 13;8(1):68. doi: 10.1038/s41541-023-00665-3. PMID: 37179389; PMCID: PMC10182552.
  7. Snoderly, H. T., Alkhadrawi, H., Panchal, D. M., Weaver, K. L., Vito, J. N., Freshwater, K. A., … Bennewitz, M. F. (2023). Short-term exposure of female BALB/cJ mice to e-cigarette aerosol promotes neutrophil recruitment and enhances neutrophil-platelet aggregation in pulmonary microvasculature. Journal of Toxicology and Environmental Health, Part A, 86(8), 246–262. https://doi.org/10.1080/15287394.2023.2184738
  8. Horspool AM, Sen-Kilic E, Malkowski AC, Breslow SL, Mateu-Borras M, Hudson MS, Nunley MA, Elliott S, Ray K, Snyder GA, Miller SJ, Kang J, Blackwood CB, Weaver KL, Witt WT, Huckaby AB, Pyles GM, Clark T, Al Qatarneh S, Lewis GK, Damron FH and Barbier M (2023) Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244. Front. Cell. Infect. Microbiol. 13:1117844. doi: 10.3389/fcimb.2023.1117844
  9. Bitzer G, Weaver K, Barbier M, Damron FH. Protocol for aerosolization challenge of mice with Bordetella pertussis. STAR Protoc. 2023 Mar 17;4(1):101979. doi: 10.1016/j.xpro.2022.101979. Epub 2023 Jan 3. PMID: 36598856; PMCID: PMC9826968.
  10.  Weaver KL, Pyles GM, Dublin SR, Huckaby AB, Miller SJ, de la Paz Gutierrez M, Sen-Kilic E, Witt WT, Boehm DT, Damron FH, and Barbier M. 2023 bioRxiv https://doi.org/10.1101/2023.03.03.530983
  11. Blackwood CB, Mateu-Borrás M, Sen-Kilic E, Pyles GM, Miller SJ, Weaver KL, Witt WT, Huckaby AB, Kang J, Chandler CE, Ernst RK, Heath Damron F, Barbier M. Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infections. NPJ Vaccines. 2022 Nov 10;7(1):143. doi: 10.1038/s41541-022-00562-1. PMID: 36357402; PMCID: PMC9649022.
  12. Weaver KL, Blackwood CB, Horspool AM, Pyles GM, Sen-Kilic E, Grayson EM, Huckaby AB, Witt WT, DeJong MA, Wolf MA, Damron FH and Barbier M (2022) Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice. Front. Immunol. 13:838504. doi: 10.3389/fimmu.2022.838504
  13. Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH,2021. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice. Infect Immun89:10.1128/iai.00607-20. https://doi.org/10.1128/iai.00607-20
  14. Sen-Kilic E, Blackwood CB, Huckaby AB, Horspool AM, Weaver KL, Malkowski AC, Witt WT, Bevere JR, Damron FH, Barbier M. 2021. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia. Infect Immun89: https://doi.org/10.1128/iai.00451-20
  15. Sen-Kilic E, Blackwood CB, Horspool AM, Huckaby AB, Weaver KL, Malkowski A, Witt WT, Bevere JR, Winters MT, Damron FH, and Barbier M. Identifying mechanistic correlates of protection against Pseudomonas aeruginosa in an acute lung pneumonia model, The Journal of Immunology, Volume 204, Issue 1_Supplement, May 2020, Page 168.8, https://doi.org/10.4049/jimmunol.204.Supp.168.8
  16. Blackwood CB, Sen-Kilic E, Weaver KL, Boehm DT, Hall JM, Wong T, Malkowski A, Witt WT, Damron FH, and Barbier M. Two for one: Identification of P. aeruginosa and B. pertussis Cross-species Antigens, The Journal of Immunology, Volume 204, Issue 1_Supplement, May 2020, Page 168.7, https://doi.org/10.4049/jimmunol.204.Supp.168.7

About Kelly Weaver

EDUCATION:

PhD, Immunology and Microbial Pathogenesis | West Virginia University, Morgantown, WV | August 2018 – December 2022

BS, Biology | Glenville State University, Glenville, WV | August 2014 – May 2018

BA, Chemistry | Glenville State University, Glenville, WV | August 2014 – May 2018

BIOGRAPHY:

I earned my PhD in Immunology and Microbial Pathogenesis in the Department of Microbiology, Immunology, and Cell Biology at West Virginia University in 2022. My dissertation research focused on understanding vaccine-induced memory responses to develop next generation pertussis vaccines.  Following my PhD I completed two and a half years as a postdoctoral researcher in the Department of Pharmacology and Toxicology at Indiana University School of Medicine and the National Institute of Occupational Safety and Health.  My research focused on the immune response and central nervous system effects of mold inhalation. With several years of research expertise in vaccine and therapeutic development I bring a unique perspective to teaching undergraduate and professional track learners. Altogether, my research background, project management experience, and strong passion for professional development allow me to serve learners and drive academic success.

As a WV native and Teaching Assistant Professor, I am dedicated to supporting learners from all backgrounds throughout their educational journey. I am especially passionate about mentoring and advising students, fostering inclusive learning environments, and supporting the next generation of learners to achieve their goals!

Kelly L. Weaver (0000-0002-6954-2479) - My ORCID

COURSES:

  1. IMMB 150 Microbiology Colloquium 1
  2. MICRO 200 Medical Microbiology Lecture
  3. IMMB 310 Bacterial Pathogenesis Lecture
  4. MICRO 323L Medical Microbiology Lab

COMMITTEE RESPONSIBILITIES:

  1. IMMB Scholarship Committee
  2. Department of Pathology, Anatomy, and Laboratory Medicine’s Academic and Professional Standards Committee
  3. Working for Impact in Science and Health, Professional Development Subcommittee
  4. Women’s Leadership Initiative